• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Kidney Biopsy Market Trends

    ID: MRFR/MED/3867-HCR
    110 Pages
    Kinjoll Dey
    October 2025

    Kidney Biopsy Market Research Report Information By End-User (Hospitals & Clinics, Urology Centers, Tertiary Care Centers and Others), By Indication (Kidney Failure, Kidney Transplant, Hematuria and Proteinuria), By Type (Percutaneous Biopsy and Surgical Biopsy), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Kidney Biopsy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Kidney Biopsy Market

    Kidney illnesses are rising worldwide, driving the kidney biopsy market. Due to diabetes, hypertension, and autoimmune illnesses, renal problems are becoming more common, increasing the need for diagnostic techniques like kidney biopsy to guide therapy. Kidney biopsy advances affect market dynamics. Imaging guided innovations like ultrasound and CT improve kidney biopsy accuracy and safety. This trend improves diagnostic accuracy and decreases complications, making kidney biopsy a trustworthy diagnostic tool. The kidney biopsy market is moving toward least invasive techniques. Patient and doctor preferences are shifting toward treatments that decrease pain, recuperation time, and problems. The rise of percutaneous kidney biopsy over open biopsy shows this trend. Ambulatory renal biopsy clinics are becoming popular. Kidney biopsies at outpatient facilities are convenient, efficient, and cost-effective for patients and doctors. This tendency matches the healthcare transition toward ambulatory care. Interventional radiology in kidney biopsy is changing market patterns. Advanced imaging helps interventional radiologists guide and execute kidney biopsies. Multidisciplinary approaches improve procedure accuracy and safety, driving kidney biopsy market growth. The kidney biopsy industry indicates customized medicine's rise. Kidney biopsies are helping diagnose diseases and inform treatment plans thanks to molecular diagnostics and genetic analysis. More tailored and effective therapy solutions result from this tendency. Kidney biopsy analysis is increasingly using AI. AI algorithms help analyze biopsy data, boosting kidney disease diagnosis speed and accuracy. This technology-driven strategy improves healthcare practitioners' skills and kidney biopsy efficiency. Kidney biopsy market trends favor patient-centeredness. Patient education, counseling, and decision-making are becoming more important in kidney biopsy operations. Information empowerment improves patient compliance and collaboration, enhancing the patient experience. Biomarker and non-invasive diagnostic research affects the kidney biopsy market. We are searching for biomarkers in blood or urine samples that can diagnose without biopsy. This tendency supports lowering patient pain and invasive intervention hazards. In the kidney biopsy business, regulatory compliance and standards are crucial. Standardised techniques and standards provide consistent biopsies, result interpretation, and patient care. Compliance with regulatory criteria improves kidney biopsy diagnostic reliability and acceptability.

    Market Summary

    As per Market Research Future Analysis, the Global Kidney Biopsy Market was valued at USD 2.31 Billion in 2024 and is projected to grow to USD 3.78 Billion by 2035, with a CAGR of 4.57% from 2025 to 2035. The market is driven by the increasing demand for chronic disease diagnostics, a rise in biopsy procedures, and advancements in biopsy techniques. The prevalence of renal diseases and the need for improved diagnostic methods are also contributing to market growth.

    Key Market Trends & Highlights

    The kidney biopsy market is witnessing significant growth due to various factors.

    • Market Size in 2024: USD 2.31 Billion Projected Market Size by 2035: USD 3.78 Billion CAGR from 2025 to 2035: 4.57% Dominant End-User Segment: Hospitals & Clinics

    Market Size & Forecast

    2024 Market Size USD 2.31 Billion
    2035 Market Size USD 3.78 Billion
    CAGR (2025-2035) 4.57%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Key players include Boston Scientific Corporation, Cook Medical, C R Bard, Inc., Devicor Medical Products Inc., Hologic Inc., and Argon Medical Devices, Inc.</p>

    Market Trends

    Rising incidence of cancer is driving the market growth

    Kidney cancer can strike individuals of any age. Kidney cancer has a wide range of signs and symptoms, but they can be difficult to distinguish from other, more common medical problems since they are non-specific. In its early stages, kidney cancer typically exhibits neither signs nor symptoms. Over time, signs and symptoms could include blood in the urine, which could be pink, red, or cola-colored; persistent back or side pain; loss of appetite; unexplained weight loss; exhaustion; and fever. Adults are most likely to develop kidney cancer than any other cancer form.

    An aggressive kidney cancer known as a Wilms tumor is more common in young children. The 14th most prevalent cancer in the world is renal cancer, also known as kidney cancer or renal cell adenocarcinoma. It ranks 14th among females and ninth among men. The number of kidney cancer diagnoses increased to around 30,000 in 2020. Kidney cancer cases are on the rise worldwide and are becoming a serious socioeconomic problem as a result of multiple risk factors like smoking, obesity, high blood pressure (hypertension), or a family history of the disease.

    In light of this, the growing number of kidney cancer patients is driving growth in the worldwide kidney biopsy market CAGR by increasing demand for renal biopsy.

    The growth and development of the kidney biopsy market have been greatly influenced by improvements in biopsy methods. These developments have enhanced the safety, accuracy, and patient experience of the biopsy technique. The market for biopsy devices is being shaped by robotically assisted systems, which also assist in preventing post-biopsy problems. Medical authorities have been approving the equipment to make the process simpler. Robot-assisted biopsy is done to boost the precision and accuracy of the biopsy process. Moreover, image-guided kidney biopsies, such as those performed using ultrasonography or computed tomography, are now more common.

    These procedures provide accurate collection and reduce the chance of problems by using real-time imaging to guide the needle exactly to the targeted kidney location. Thus, driving the kidney biopsy market revenue.

    <p>The increasing prevalence of chronic kidney diseases and the growing demand for accurate diagnostic procedures are driving advancements in kidney biopsy techniques and technologies.</p>

    U.S. National Institute of Diabetes and Digestive and Kidney Diseases

    Kidney Biopsy Market Market Drivers

    Market Growth Projections

    The Global Kidney Biopsy Market Industry is expected to experience substantial growth over the coming years. Projections indicate that the market will reach 2.31 USD Billion in 2024 and further expand to 3.78 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 4.59% from 2025 to 2035, suggesting a robust demand for kidney biopsy procedures. Factors contributing to this growth include the increasing prevalence of kidney diseases, advancements in biopsy techniques, and heightened awareness of kidney health. These dynamics collectively indicate a promising future for the kidney biopsy market.

    Growing Geriatric Population

    The aging population worldwide is a significant factor propelling the Global Kidney Biopsy Market Industry. As individuals age, the risk of developing kidney-related ailments increases, necessitating more frequent diagnostic evaluations. The United Nations projects that the global population aged 65 and older will reach 1.5 billion by 2050, highlighting the urgent need for effective kidney disease management strategies. This demographic shift is likely to result in a higher demand for kidney biopsies, as healthcare providers seek to accurately diagnose and treat age-related kidney conditions. Consequently, the market is poised for growth, driven by the increasing healthcare needs of the elderly.

    Enhanced Reimbursement Policies

    Improved reimbursement policies for kidney biopsy procedures are positively impacting the Global Kidney Biopsy Market Industry. Many healthcare systems are recognizing the necessity of kidney biopsies for accurate diagnosis and treatment planning, leading to more favorable reimbursement rates. This shift encourages healthcare providers to perform biopsies more frequently, as financial barriers are reduced. As reimbursement frameworks evolve, the accessibility of kidney biopsies is likely to improve, fostering market growth. The anticipated increase in procedures aligns with the overall market expansion, as stakeholders adapt to changing healthcare policies that support kidney disease diagnostics.

    Rising Awareness and Screening Programs

    Increased awareness regarding kidney health and the importance of early detection is driving the Global Kidney Biopsy Market Industry. Public health initiatives and screening programs aimed at identifying individuals at risk of kidney diseases have gained momentum. These programs often emphasize the need for kidney biopsies as a vital diagnostic tool. As more individuals undergo screening, the demand for kidney biopsies is likely to rise, contributing to market growth. This heightened awareness aligns with the projected compound annual growth rate (CAGR) of 4.59% from 2025 to 2035, reflecting a sustained interest in proactive kidney health management.

    Increasing Prevalence of Kidney Diseases

    The rising incidence of kidney diseases globally is a primary driver for the Global Kidney Biopsy Market Industry. Chronic kidney disease (CKD) affects millions worldwide, with the World Health Organization reporting that approximately 10% of the global population suffers from some form of kidney impairment. This growing patient population necessitates accurate diagnostic methods, including kidney biopsies, to assess the extent of kidney damage and guide treatment options. As the demand for kidney biopsies increases, the market is projected to reach 2.31 USD Billion in 2024, indicating a robust growth trajectory fueled by the urgent need for effective kidney disease management.

    Technological Advancements in Biopsy Techniques

    Innovations in biopsy techniques are significantly influencing the Global Kidney Biopsy Market Industry. The introduction of minimally invasive procedures, such as ultrasound-guided biopsies, enhances patient safety and comfort while improving diagnostic accuracy. These advancements reduce complications and recovery times, making kidney biopsies more appealing to both patients and healthcare providers. As technology continues to evolve, the market is expected to expand, with projections indicating a growth to 3.78 USD Billion by 2035. This trend suggests that ongoing research and development in biopsy methodologies will play a crucial role in shaping the future landscape of kidney diagnostics.

    Market Segment Insights

    Kidney Biopsy End-User Insights

    <p>The &nbsp;kidney biopsy market segmentation, based on end-user includes Hospitals &amp; Clinics, Urology Centers, Tertiary Care Centers and Others. The hospitals &amp; clinics segment dominated the market. The majority of kidney biopsy operations are carried out in hospitals &amp; clinics. In addition to diagnostic procedures like kidney biopsies, they offer a wide range of healthcare services. Kidney biopsies can be completed in hospitals thanks to its infrastructure, medical staff, and equipment.</p>

    Kidney Biopsy Indication Insights

    <p>The kidney biopsy market segmentation, based on indication, includes Kidney Failure, Kidney Transplant, Hematuria and Proteinuria. The kidney transplant category generated the most income. In the context of kidney transplantation, kidney biopsies are frequently conducted. Prior to transplantation, biopsies are performed to evaluate the appropriateness of the donor organ and guarantee compatibility with the recipient. In order to monitor the transplanted kidney's health and functionality, spot any signs of rejection or other issues, and inform treatment choices, post-transplant biopsies are carried out.</p>

    Kidney Biopsy Type Insights

    <p>The &nbsp;kidney biopsy market segmentation, based on type includes Percutaneous Biopsy&nbsp;and Surgical Biopsy. The percutaneous biopsy&nbsp; segment dominated the market. The most frequent and commonly utilised type of kidney biopsy is percutaneous. In order to get a tissue sample, a biopsy needle must be inserted through the skin and into the kidney. Typically, local anesthesia is used during this surgery, and imaging methods like CT scans or ultrasounds are used to accurately pinpoint the biopsy location.</p>

    <p>Figure 1 &nbsp;Kidney Biopsy Market, by Type, 2023 &amp; 2032 (USD Billion)</p>

    <p>Source Secondary Research, Primary Research, MRFR Database and Analyst Review</p>

    Get more detailed insights about Kidney Biopsy Market Research Report– Forecast till 2032

    Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American kidney biopsy market area will dominate this market. The high costs of healthcare, government funding of R&D, widespread use of technologically advanced medical devices for kidney disease diagnosis and treatment, an increase in the number of kidney disease patients, diabetes, and other risk factors for renal failure, as well as the high spending on health care, are all factors driving the growth of the regional market.

    The number of patients with diabetes, kidney disease, and other risk factors for renal failure is rising, which is also driving the market. Expanding usage of new technologies for treating ailments, favorable reimbursement rules, and significant investments in their development will propel market growth.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2  KIDNEY BIOPSY MARKET SHARE BY REGION 2023 (USD Billion)KIDNEY BIOPSY MARKET SHARE BY REGION 2022

    Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    Europe kidney biopsy market accounts for the second-largest market share. The growth of the regional market is attributed to the availability of research funding, rising government support for R&D, increasing emphasis on the development of cutting-edge diagnostic tools in urology, and an increase in the number of specialty services offered by various healthcare providers. Additionally, it is anticipated that increased applications, sizable expenditures, and favorable reimbursement rules will all improve the performance of the regional market.

    Further, the German kidney biopsy market held the largest market share, and the UK kidney biopsy market was the fastest growing market in the European region

    The Asia-Pacific Kidney biopsy Market is expected to grow at the fastest CAGR from 2024 to 2032 due to the rising prevalence of diabetes and the rise in kidney transplant surgeries performed in urology clinics. The market is also fueled by increased healthcare spending and the quickly expanding healthcare technology sector. Additionally, growing demand for high-quality medical devices is probably going to result in higher use of cutting-edge technology, speeding up market expansion in this sector.

    Moreover, China’s kidney biopsy market held the largest market share, and the Indian kidney biopsy market was the fastest growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the kidney biopsy market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, kidney biopsy industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  kidney biopsy industry to benefit clients and increase the market sector. In recent years, the kidney biopsy industry has offered some of the most significant advantages to market.

    Major players in the kidney biopsy market attempting to increase market demand by investing in research and development operations include Boston Scientific Corporation (U.S.), Cook Medical (U.S.), C R Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), Hologic Inc. (U.S.), Intact Medical Corporation (U.S.), Precision Biopsy, LLC (U.S.), Scion Medical Technologies LLC (U.S.), Integra LifeSciences Corporation (U.S.), Creganna (U.S.), Focal Therapeutics, Inc. (U.S.), CareFusion (U.S.), Argon Medical Devices, Inc. (U.S.) and others.

    With its headquarters in Plano, Texas, Argon Medical is a maker of speciality medical goods on a  scale. Vascular surgery, interventional cardiology, interventional radiology, and oncology all have a variety of medical equipment available from Argon. The Argon brand is known for top-of-the-line solutions that enhance patient outcomes through percutaneous, image-guided operations. Argon supports its international customers through a direct sales organisation and through enduring connections with OEMs, strategic partners, and medical device distributors by utilizing a well-established sales and marketing infrastructure.

    Over 1000 people work at Argon worldwide in manufacturing facilities in Athens, Texas, Wheeling, Illinois, Rochester, New York, and Portage, Wisconsin.

    Cook Medical Inc., a division of Cook Group Inc., is a manufacturer, distributor, and developer of medical devices for minimally invasive procedures. Catheters, grafts, stents, plugs, wire guides, needles, balloons, feeding tubes, and extractors are among the main items produced by the company. Among other specialties, it provides goods and services in anesthesiology, bariatrics, cardiothoracic, general, gynecologic oncology, gynecology, neurosurgery, colorectal, endovascular, peripheral cardiology, plastic surgery, traumatology, urogynecology, and urology.

    Key Companies in the Kidney Biopsy Market market include

    Industry Developments

    September 2021 Natera, Inc., a leader in cell-free DNA (cfDNA) testing, recently unveiled Prospera with Quantification, the only cfDNA test for kidney rejection that provides three values on each report total cfDNA, the percentage of donor-derived cfDNA, and the amount of donor-derived cfDNA (dd-cfDNA). Comparatively to using the dd-cfDNA fraction alone, it has been suggested that combining these three measures will increase sensitivity for determining transplant rejection.

    May 2021 AVROBIO, Inc., a pioneer in the field of clinical-stage gene therapy, provided an update on its regulatory preparations for AVR-RD-01, the first investigational lentiviral gene therapy for Fabry disease. The change is in response to the most recent regulatory advancement for Fabry disease treatments in the US.

    Future Outlook

    Kidney Biopsy Market Future Outlook

    <p>The Kidney Biopsy Market is projected to grow at a 4.57% CAGR from 2025 to 2035, driven by advancements in diagnostic technologies and increasing prevalence of kidney diseases.</p>

    New opportunities lie in:

    • <p>Develop minimally invasive biopsy techniques to enhance patient comfort and recovery. Invest in AI-driven diagnostic tools for improved accuracy in biopsy analysis. Expand telemedicine services for remote biopsy consultations and follow-ups.</p>

    <p>By 2035, the Kidney Biopsy Market is expected to demonstrate robust growth, reflecting advancements in technology and increased healthcare access.</p>

    Market Segmentation

    Kidney Biopsy Type Outlook (USD Billion, 2018-2032)

    • Percutaneous Biopsy 
    • Surgical Biopsy

    Kidney Biopsy End-User Outlook (USD Billion, 2018-2032)

    • Hospitals & Clinics
    • Urology Centers
    • Tertiary Care Centers
    • Others

    Kidney Biopsy Regional Outlook (USD Billion, 2018-2032)

    • {"North America"=>["US"
    • "Canada"]}
    • {"Europe"=>["Germany"
    • "France"
    • "UK"
    • "Italy"
    • "Spain"
    • "Rest of Europe"]}
    • {"Asia-Pacific"=>["China"
    • "Japan"
    • "India"
    • "Australia"
    • "South Korea"
    • "Rest of Asia-Pacific"]}
    • {"Rest of the World"=>["Middle East"
    • "Africa"
    • "Latin America"]}

    Kidney Biopsy Indication Outlook (USD Billion, 2018-2032)

    • Kidney Failure
    • Kidney Transplant
    • Hematuria
    • Proteinuria

    Report Scope

     

    Attribute/MetricDetails
    Market Size 2024USD 2.31 Billion
    Market Size 20353.78 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR)4.57% (2025 - 2035)
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2018- 2022
    Market Forecast UnitsValue (USD Billion)
    Report CoverageRevenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments CoveredEnd-User, Indication, Type and Region
    Geographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the World
    Countries CoveredThe US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies ProfiledBoston Scientific Corporation (U.S.), Cook Medical (U.S.), C R Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), Hologic Inc. (U.S.), Intact Medical Corporation (U.S.), Precision Biopsy, LLC (U.S.), Scion Medical Technologies LLC (U.S.), Integra LifeSciences Corporation (U.S.), Creganna (U.S.), Focal Therapeutics, Inc. (U.S.), CareFusion (U.S.), Argon Medical Devices, Inc. (U.S.) and others
    Key Market OpportunitiesEstablished market players in flourishing nations drive ization by providing new goods and services to developing nations and rising economies
    Key Market DynamicsIncreasing number of biopsy proceduresRising demand for new techniques for diagnosis of chronic diseases
    Market Size 20252.42 (Value (USD Billion))

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Kidney Biopsy market?

    The Kidney Biopsy market is the expected increase in total market value of 3.78 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Kidney Biopsy market?

    Kidney Biopsy market size was valued at approximately 2.31 billion USD in 2024. This figure will reach 3.78 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Kidney Biopsy market?

    Kidney Biopsy market is expected to grow at a CAGR of 4.57% between 2025 and 2035.

    How much will the Kidney Biopsy market be worth by 2035?

    Kidney Biopsy market is expected to be worth of 3.78 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Kidney Biopsy market perform over the next 10 years?

    Over the next 10 years the Kidney Biopsy market is expected to shift from usd billion 2.31 to 3.78 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the kidney biopsy market?

    North America had the largest share in the market.

    1. Table Of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power Of Suppliers
        2. Bargaining Power Of Buyers
        3. Threat Of New Entrants
        4. Threat Of Substitutes
        5. Intensity Of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Global Kidney Biopsy Market, By Type
      1. Introduction
      2. Percutaneous Biopsy
        1. Market Estimates & Forecast, 2023-2032
      3. Surgical Biopsy
        1. Market Estimates & Forecast, 2023-2032 7. Global Kidney Biopsy Market, By Indication
      4. Introduction
      5. Hematuria
        1. Market Estimates & Forecast, 2023-2032
      6. Kidney Failure
        1. Market Estimates & Forecast, 2023-2032
      7. Proteinuria
        1. Market Estimates & Forecast, 2023-2032
      8. Kidney Transplant
        1. Market Estimates & Forecast, 2023-2032
      9. Others
        1. Market Estimates & Forecast, 2023-2032
    8. Global Kidney Biopsy Market, By End User
      1. Introduction
      2. Hospitals & Clinics
        1. Market Estimates & Forecast, 2023-2032
      3. Tertiary Care Centers
        1. Market Estimates & Forecast, 2023-2032
      4. Urology Centers
        1. Market Estimates & Forecast, 2023-2032
      5. Others
        1. Market Estimates & Forecast, 2023-2032
    9. Global Kidney Biopsy Market, By Region
      1. Introduction
      2. Americas
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic Of Korea
        6. Rest Of Asia Pacific
      5. The Middle East & Africa
        1. United Arab Emirates
        2. Saudi Arabia
        3. Oman
        4. Kuwait
        5. Qatar
        6. Rest Of The Middle East & Africa
    10. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    11. Company Profiles
      1. Cook Medical
        1. Company Overview
        2. Indication Overview
        3. Financials
        4. SWOT Analysis
      2. Boston Scientific Corporation
        1. Company Overview
        2. Indication Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Hologic Inc.
        1. Company Overview
        2. Indication Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Devicor Medical Products Inc.
        1. Company Overview
        2. Indication/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. C. R. Bard, Inc.
        1. Company Overview
        2. Indication Overview
        3. Financial Overview
        4. Key Developments
      6. Intact Medical Corporation
        1. Overview
        2. Indication Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      7. Precision Biopsy, LLC
        1. Overview
        2. Indication Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Scion Medical Technologies LLC
        1. Overview
        2. Indication Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Others
    12. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs Of The Market
      2. Key Companies To Watch
      3. Prediction Of Medical Device Industry
    13. Appendix
    14. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Kidney Biopsy Industry Synopsis, 2023-2032
      3. Table 2 Global Kidney Biopsy Market Estimates And Forecast, 2023-2032, (USD Million)
      4. Table 3 Global Kidney Biopsy Market By Region, 2023-2032, (USD Million)
      5. Table 4 Global Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      6. Table 5 Global Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      7. Table 7 Global Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      8. Table 8 North America Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      9. Table 9 North America Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      10. Table 11 North America Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      11. Table 12 U.S. Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      12. Table 13 U.S. Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      13. Table 15 U.S. Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      14. Table 16 Canada Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      15. Table 17 Canada Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      16. Table 19 Canada Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      17. Table 20 South America Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      18. Table 21 South America Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      19. Table 23 South America Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      20. Table 24 Europe Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      21. Table 25 Europe Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      22. Table 27 Europe Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      23. Table 28 Western Europe Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      24. Table 29 Western Europe Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      25. Table 31 Western Europe Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      26. Table 32 Eastern Europe Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      27. Table 33 Eastern Europe Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      28. Table 35 Eastern Europe Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      29. Table 36 Asia Pacific Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      30. Table 37 Asia Pacific Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      31. Table 39 Asia Pacific Kidney Biopsy Market By End Users, 2023-2032, (USD Million)
      32. Table 40 Middle East & Africa Kidney Biopsy Market By Types, 2023-2032, (USD Million)
      33. Table 41 Middle East & Africa Kidney Biopsy Market By Indication, 2023-2032, (USD Million)
      34. Table 43 Middle East & Africa Kidney Biopsy Market By End Users, 2023-2032, (USD Million) LIST OF FIGURES
      35. Figure 1 Research Process
      36. Figure 2 Segmentation For Global Kidney Biopsy Market
      37. Figure 3 Segmentation Market Dynamics For Kidney Biopsy Market
      38. Figure 4 Global Kidney Biopsy Market Share, By Type, 2020
      39. Figure 5 Global Kidney Biopsy Market Share, By Indication, 2020
      40. Figure 6 Global Kidney Biopsy Market Share, By End Users, 2020
      41. Figure 7 Global Kidney Biopsy Market Share, By Region, 2020
      42. Figure 8 North America Kidney Biopsy Market Share, By Country, 2020
      43. Figure 9 Europe Kidney Biopsy Market Share, By Country, 2020
      44. Figure 10 Asia Pacific Kidney Biopsy Market Share, By Country, 2020
      45. Figure 11 Middle East & Africa Kidney Biopsy Market Share, By Country, 2020
      46. Figure 12 Global Kidney Biopsy Market: Company Share Analysis, 2020 (%)
      47. Figure 13 Cook Medical: Key Financials
      48. Figure 14 Cook Medical: Segmental Revenue
      49. Figure 16 Cook Medical: Geographical Revenue
      50. Figure 17 Boston Scientific Corporation: Key Financials
      51. Figure 18 Boston Scientific Corporation: Segmental Revenue
      52. Figure 19 Boston Scientific Corporation: Geographical Revenue
      53. Figure 20 Hologic Inc.: Key Financials
      54. Figure 21 Hologic Inc.: Segmental Revenue
      55. Figure 22 Hologic Inc.: Geographical Revenue
      56. Figure 23 Devicor Medical Products Inc.: Key Financials
      57. Figure 24 Devicor Medical Products Inc.: Segmental Revenue
      58. Figure 25 Devicor Medical Products Inc.: Geographical Revenue
      59. Figure 26 Scion Medical Technologies LLC: Key Financials
      60. Figure 27 Scion Medical Technologies LLC: Segmental Revenue
      61. Figure 28 Scion Medical Technologies LLC: Geographical Revenue
      62. Figure 29 C. R. Bard, Inc.: Key Financials
      63. Figure 30 C. R. Bard, Inc.: Segmental Revenue
      64. Figure 31 C. R. Bard, Inc.: Geographical Revenue
      65. Figure 32 Intact Medical Corporation: Key Financials
      66. Figure 33 Intact Medical Corporation: Segmental Revenue
      67. Figure 34 Intact Medical Corporation: Geographical Revenue

    Kidney Biopsy Market Segmentation

    Kidney Biopsy End-User Outlook (USD Billion, 2018-2032)

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Kidney Biopsy Indication Outlook (USD Billion, 2018-2032)

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Kidney Biopsy Type Outlook (USD Billion, 2018-2032)

    Percutaneous Biopsy

    Surgical Biopsy

    Kidney Biopsy Regional Outlook (USD Billion, 2018-2032)

    North America Outlook (USD Billion, 2018-2032)

    North America Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    North America Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    North America Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    US Outlook (USD Billion, 2018-2032)

    US Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    US Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    US Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Canada Outlook (USD Billion, 2018-2032)

    Canada Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Canada Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Canada Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Europe Outlook (USD Billion, 2018-2032)

    Europe Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Europe Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Europe Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Germany Outlook (USD Billion, 2018-2032)

    Germany Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Germany Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Germany Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    France Outlook (USD Billion, 2018-2032)

    France Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    France Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    France Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    UK Outlook (USD Billion, 2018-2032)

    UK Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    UK Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    UK Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Italy Outlook (USD Billion, 2018-2032)

    Italy Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Italy Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Italy Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Spain Outlook (USD Billion, 2018-2032)

    Spain Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Spain Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Spain Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Rest Of Europe Outlook (USD Billion, 2018-2032)

    Rest Of Europe Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Rest Of Europe Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Rest Of Europe Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Asia-Pacific Outlook (USD Billion, 2018-2032)

    Asia-Pacific Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Asia-Pacific Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Asia-Pacific Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    China Outlook (USD Billion, 2018-2032)

    China Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    China Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    China Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Japan Outlook (USD Billion, 2018-2032)

    Japan Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Japan Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Japan Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    India Outlook (USD Billion, 2018-2032)

    India Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    India Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    India Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Australia Outlook (USD Billion, 2018-2032)

    Australia Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Australia Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Australia Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

    Rest of Asia-Pacific Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Rest of Asia-Pacific Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Rest of Asia-Pacific Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Rest of the World Outlook (USD Billion, 2018-2032)

    Rest of the World Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Rest of the World Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Rest of the World Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Middle East Outlook (USD Billion, 2018-2032)

    Middle East Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Middle East Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Middle East Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Africa Outlook (USD Billion, 2018-2032)

    Africa Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Africa Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Africa Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Latin America Outlook (USD Billion, 2018-2032)

    Latin America Kidney Biopsy by End-User

    Hospitals & Clinics

    Urology Centers

    Tertiary Care Centers

    Others

    Latin America Kidney Biopsy by Indication

    Kidney Failure

    Kidney Transplant

    Hematuria

    Proteinuria

    Latin America Kidney Biopsy by Type

    Percutaneous Biopsy

    Surgical Biopsy

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials